BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15285315)

  • 1. The value of epithelial membrane antigen overexpression in hyperplastic and malignant endometrium and its relationship with steroid hormone receptor expression.
    Kir G; Cetiner H; Gurbuz A; Karateke A
    Eur J Gynaecol Oncol; 2004; 25(4):502-5. PubMed ID: 15285315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1).
    Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Makrydimas G; Salmas M; Agnantis NJ
    Eur J Gynaecol Oncol; 2003; 24(3-4):299-304. PubMed ID: 12807244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
    Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
    Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
    Niikura H; Sasano H; Kaga K; Sato S; Yajima A
    Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
    Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of epithelial membrane antigen overexpression in benign and malignant endometrium.
    Coronado PJ; Fasero M; Vidart JA; Puerta J; Magrina J; Furio-Bacete V; Escudero M
    Gynecol Oncol; 2001 Sep; 82(3):483-8. PubMed ID: 11520144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.
    Kreizman-Shefer H; Pricop J; Goldman S; Elmalah I; Shalev E
    Diagn Pathol; 2014 Mar; 9():77. PubMed ID: 24684970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
    Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ
    Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
    Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
    Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
    Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
    Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.